Tag Archives: high-density lipoprotein
August 2012 Br J Cardiol 2012;19:107–10
HDL particles may be key to risk
BJCardio Staff
While the failure of the first cholesterylester transfer protein (CETP) inhibitor, torcetrapib, was blamed on its side effect of raising blood pressure, three more negative trials have also now cast doubt on the value of boosting HDL – AIM-HIGH with niacin, dal-OUTCOMES with dalcetrapib, and a genetic study published earlier this year in The Lancet, showing that people carrying gene variants coding for increased HDL levels did not have a reduced risk of heart disease. However, in a new analysis of the Multi-Ethnic Study of Atherosclerosis (MESA), published on July 11 in the Journal of the American College of Cardiology (http://dx.doi.org/10
March 2006 Br J Cardiol 2006;13:131-6
The failure of LDL cholesterol reduction and the importance of reverse cholesterol transport. The role of nicotinic acid
H Robert Superko
No content available
For healthcare professionals only
